BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3148705)

  • 1. Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro.
    Nacucchio MC; Gatto Bellora MJ; Sordelli DO; D'Aquino M
    J Microencapsul; 1988; 5(4):303-9. PubMed ID: 3148705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
    Rukholm G; Mugabe C; Azghani AO; Omri A
    Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Mugabe C; Azghani AO; Omri A
    J Antimicrob Chemother; 2005 Feb; 55(2):269-71. PubMed ID: 15590716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of gram-negative bacilli against gentamicin.
    Sharma KB; Madhavan HN; Dasgupta LR; Krishnan AD; Ravindran PC
    Indian J Med Res; 1969 Nov; 57(11):2013-5. PubMed ID: 4986570
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial activity of piperacillin and gentamicin using a dynamic system simulating in vivo pharmacokinetics.
    Blenkharn JI
    J Chemother; 1989 Jul; 1(4 Suppl):487-9. PubMed ID: 16312497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-antibiotic effect induced by an antibiotic combination: influence of altered susceptibility to individual components.
    Li RC; Tang MC
    J Antimicrob Chemother; 2005 Apr; 55(4):583-6. PubMed ID: 15728143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin].
    Wundt W; Lange KP; Baumgärtner M
    Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa.
    Lagacé J; Dubreuil M; Montplaisir S
    J Microencapsul; 1991; 8(1):53-61. PubMed ID: 1908898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
    Welch DF; Matsen JM
    Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
    Baier R; Puppel H
    Med Klin; 1979 Dec; 74(50):1923-7. PubMed ID: 120489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
    Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
    Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains.
    Drulis-Kawa Z; Gubernator J; Dorotkiewicz-Jach A; Doroszkiewicz W; Kozubek A
    Int J Pharm; 2006 Jun; 315(1-2):59-66. PubMed ID: 16551496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative antibacterial activity of piperacillin against Pseudomonas aeruginosa, Escherichia coli and Streptococcus faecalis in cultures and human serum].
    Just HM; Reiber T; Bassler M; Daschner FD
    Immun Infekt; 1985 May; 13(3):119-23. PubMed ID: 3924819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the in vitro activity of dibekacin, piperacillin, cefotaxime and cefuroxime on gram-negative bacteria].
    Carlone NA; Cuffini AM; Forno-Pizzoglio M
    G Batteriol Virol Immunol; 1983; 76(7-12):239-45. PubMed ID: 6099296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibacterial activity of gentamicin in the glucosuric environment.
    Papapetropoulou M; Giamarellou H
    Drugs Exp Clin Res; 1985; 11(11):793-5. PubMed ID: 3939216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.